Kliniska studier för KOL i Louisiana
9 studier för KOL söker deltagare vid platser i Louisiana.
Städer i Louisiana
Officiell studietext (engelska)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Lafayette
- Research Site, Monroe
- Research Site, Shreveport
- och 1 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
- Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Lake Charles
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 sep. 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Zachary
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Southern Clinical Research, LLC, Zachary
RekryterarFas 2/3
Ålder 35 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07363694STRIVE Post-Market Registry Study
- LSU Health Shreveport, Shreveport
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lake Charles
- GSK Investigational Site, Shreveport
RekryterarFas 3
Ålder 40 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Baton Rouge
- GSK Investigational Site, Lafayette
- GSK Investigational Site, Shreveport
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 apr. 2026 · NCT06961214Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.